Effects of phosphoinositide 3-kinase inhibitor SHBM1009 on cancer cells proliferation
AbstractAbstract: Phosphoinositide 3-kinase (PI3K) plays an important role in cellular proliferation and tumor progression. The objective of this study is to evaluate the potential mechanism and therapeutic effects of new PI3K inhibitor SHBM1009 on various cancer cells of digestive system on proliferation.
L.M. Thorpe, H. Yuzugullu, J.J. Zhao.PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting.Nat Rev Cancer 2015 Jan; 15(1):7-24.
R. Frankson, Z.H. Yu, Y. Bai, Q. Li, R.Y. Zhang, Z.Y. Zhang.Therapeutic targeting of oncogenic tyrosine phosphatases. Cancer Res 2017 Aug 30 ; doi: 10.1158/0008-5472.
J. Downward.Targeting RAS and PI3K in lung cancer.
Nat Med 2008 Dec; 14(12):1315-6.
A. Arcaro.Targeting PI3K/mTOR Signaling in Cancer. Front Oncol 2014 Apr 22;4:84.
J. Zhao, C. Chen, H. Zhang, J. Shen, X. Lin, L. Qin,
X. Bao, J. Lin, W. Lu, X. Wang, X. Chen.Evaluation of cloned cells, animal model, and ATRA sensitivity of human testicular yolk sac tumor.J Transl Med 2012 Mar 13;10:46.
X. Fang, K. Li, X. Tao, C. Chen, X. Wang, L. Wang, D.C. Wang, Y. Zhang, C. Bai.Effects of phosphoinositide 3-kinase on protease-induced acute and chronic lung inflammation, remodeling, and emphysema in rats. Chest 2013 Apr; 143(4):1025-35.
C. Perez- Ramirez, M. Canadas- Garre, M. A.
Molina, M.J. Faus-Dader, M.A. Calleja-Hernandez.
PTEN and PI3K/AKT in non-small-cell lung cancer. Pharmacogenomics 2015 Nov; 16(16):1843-62.
D. Bashash, M. Delshad, A. Safaroghli-Azar, M. Safa,
M. Momeny, S.H. Ghaffari.Novel pan PI3K inhibitor- induced apoptosis in APL cells correlates with suppression of telomerase: An emerging mechanism of action of BKM120.Int J Biochem Cell Biol 2017 Aug 20; 91(Pt A):1-8.
F. Bozorg-Ghalati, M. Hedayati, M. Dianatpour,
F. Azizi, N. Mosaffa, D. Mehrabani.Effects of a Phosphoinositide-3-Kinase Inhibitor on Anaplastic Thyroid Cancer Stem Cells.Asian Pac J Cancer Prev 2017 Aug 27; 18(8):2287-2291.
K.K.W. To, L.W. Fu.CUDC-907, a dual HDAC and PI3K inhibitor, reverses platinum drug resistance. Invest New Drugs 2017 Aug 17; doi: 10.1007/ s10637-017-0501-9.
X. Zhang, I.H. Jung, Y.S. Hwang.EGF enhances low- invasive cancer cell invasion by promoting IMP-3 expression.Tumour biology 2016 Feb; 37(2): 2556-63.
T. J . L y n c h , D . W . B e l l , R . S o r d e l l a , S .
Gurubhagavatula, R.A. Okimoto, B.W. Brannigan,
P.L. Harris, S.M. Haserlat, J.G. Supko, F.G. Haluska,
D.N. Louis, D.C. Christiani, J. Settleman, D.A. Haber. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.N Engl J Med 2004 May 20; 350(21):2129-39.
F. Walker, L. Abramowitz, D. Benabderrahmane, X. Duval, V. Descatoire, D. Henin, T. Lehy, T. Aparicio. Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency
virus.Hum Pathol 2009 Nov; 40(11):1517-27.
R. Jackson, E.E. Psarelli, S. Berhane, H. Khan, P. Johnson.Impact of Viral Status on Survival in Patients Receiving Sorafenib for Advanced Hepatocellular Cancer: A Meta-Analysis of Randomized Phase III Trials.J Clin Oncol 2017 Feb 20; 35(6):622-628.
Y. Zhang, L. Wang, M. Zhang, M. Jin, C. Bai, X. Wang. Potential mechanism of interleukin-8 production from lung cancer cells: an involvement of EGF-EGFR- PI3K-Akt-Erk pathway.J Cell Physiol 2012 Jan; 227(1):35-43.
R.J. Reddy, A.S. Gajadhar, E.J. Swenson, D.A. Rothenberg, T.G. Curran, F.M. White.Early signaling dynamics of the epidermal growth factor receptor.Proc Natl Acad Sci U S A 2016 Mar 15; 113(11):3114-9.
Prawan A, Saw CL, Khor TO, Keum YS, Yu S, Hu L, Kong AN. Anti-NF-kappaB and anti-inflammatory activities of synthetic isothiocyanates: effect of chemical structures and cellular signaling. Chem Biol Interact. 2009 May; 179(2-3): 202-11.
L. Shi, N. Dong, X. Fang, X. Wang.Regulatory mechanisms of TGF-beta1-induced fibrogenesis of human alveolar epithelial cells.J Cell Mol Med 2016 Nov; 20(11): 2183-2193.
Y. Yu, X. Yu, J. Ma, Y. Tong, J. Yao.Effects of NVP- BEZ235 on the proliferation, migration, apoptosis and autophagy in HT-29 human colorectal adenocarcinoma cells.Int J Oncol 2016 Jul; 49(1):285-93.
L. Shi, L. Wang, B. Wang, S.M. Cretoiu, Q. Wang, X. Wang, C. Chen.Regulatory mechanisms of betacellulin in CXCL8 production from lung cancer cells.J Transl Med 2014 Mar 16; 12:70.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright on any open access article in Molecular and Cellular Therapies published bythe Institute is retained by the author(s). Authors can grant any third party the right to use
the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified. Please contact the Office of Molecular and Cellular
Therapies for more information specifically regarding permissions if there are questions.